Laurence Christa

Title: Laurence Christa: Innovator in Liver Regeneration

Introduction

Laurence Christa is a notable inventor based in Bourg la Reine, France. He has made significant contributions to the field of liver regeneration through his innovative research and patent.

Latest Patents

Laurence Christa holds a patent for a "Method for using HIP/PAP polypeptide composition for liver regeneration and prevention of liver failure." This invention is grounded in the experimental finding that HIP/PAP exhibits mitogenic and anti-apoptotic effects on hepatocytes in primary culture. Furthermore, HIP/PAP serves as a mitogenic and anti-apoptotic molecule for hepatocytes in vivo during liver failure and regeneration. The invention also highlights that HIP/PAP administration has no adverse effects in mammals. The pharmaceutical composition aims to stimulate liver regeneration in vivo, particularly after chronic or acute liver failure, and includes an effective amount of a polypeptide with a specific amino acid sequence, combined with at least one physiologically acceptable excipient.

Career Highlights

Throughout his career, Laurence Christa has worked with esteemed institutions such as the National Institute of Health and Medical Research and Université René Descartes. His work has been pivotal in advancing the understanding of liver regeneration mechanisms.

Collaborations

Laurence has collaborated with notable colleagues, including Marie-Thérèse Simon-Gage-Soufflot and Alain Pauloin. Their combined expertise has contributed to the success of his research endeavors.

Conclusion

Laurence Christa's innovative work in liver regeneration showcases the potential of HIP/PAP polypeptide compositions in medical applications. His contributions to the field are invaluable and highlight the importance of continued research in this area.